SpareBank 1 Markets

SpareBank 1 Markets is a Norwegian investment bank within the capital markets area. We offer highly qualified staff, a top-ranked research team and strong investment, risk and balance sheet capability through our participating banks.

Contact us today

SpareBank 1 Markets

SpareBank 1 Markets is a Norwegian investment bank within the capital markets area. We offer highly qualified staff, a top-ranked research team and strong investment, risk and balance sheet capability through our participating banks.
ARTICLES

Nordic short report - Week 40 2016

NAS short interest down 52bp to 15.8

Conclusion
Unweighted average Nordic short interest (SI) up 11bp WoW to 4.2%

• Our new quantitative SI trading model indicate three buys and one sell among OBX shares
• Energy sector SI remains in low end of two-year band

Read more
NEWS

Nordic Financial 4Q 2015 Preview

Strong Swedish macro supportive
Upbeat Swedish macro but World Economic Forum see increased risks aheadWe expect NII to be more or less flat from Q3, as effects from lower interest rates balance lending growth and margin improvements. Furthermore we expect both the NII pressure and the regulatory headwind to continue in 2016. We previously lowered our dividend payout ratios in all of the Swedish banks by 5% to avg. 62.5%, but even after the adjustment the Swedish banks yields 5.8% (15e) which we find very attractive. More importantly we find a 5% leverage ratio obtainable for all the Swedes.

Read more
ONGOING TRANSACTIONS

Bionor Pharma ASA – Rights Issue

SpareBank 1 Markets is acting as Manager in relation to a Private Placement and a Rights Issue in Bionor Pharma ASA with total gross proceeds of NOK 105 million. The subscription period for the Rights Issue is from and including 15 September 2016 to 16:30 (CET) on 29 September 2016.

Read more
ARTICLES

Nordic short report - Week 40 2016

NAS short interest down 52bp to 15.8

Conclusion
Unweighted average Nordic short interest (SI) up 11bp WoW to 4.2%

• Our new quantitative SI trading model indicate three buys and one sell among OBX shares
• Energy sector SI remains in low end of two-year band

Read more
NEWS

Nordic Financial 4Q 2015 Preview

Strong Swedish macro supportive
Upbeat Swedish macro but World Economic Forum see increased risks aheadWe expect NII to be more or less flat from Q3, as effects from lower interest rates balance lending growth and margin improvements. Furthermore we expect both the NII pressure and the regulatory headwind to continue in 2016. We previously lowered our dividend payout ratios in all of the Swedish banks by 5% to avg. 62.5%, but even after the adjustment the Swedish banks yields 5.8% (15e) which we find very attractive. More importantly we find a 5% leverage ratio obtainable for all the Swedes.

Read more
ONGOING TRANSACTIONS

Bionor Pharma ASA – Rights Issue

SpareBank 1 Markets is acting as Manager in relation to a Private Placement and a Rights Issue in Bionor Pharma ASA with total gross proceeds of NOK 105 million. The subscription period for the Rights Issue is from and including 15 September 2016 to 16:30 (CET) on 29 September 2016.

Read more
 
 

Contact

P(+47) 24 14 74 00

F(+47) 24 14 74 01

Einfo@sb1markets.no

Office Address Oslo

Olav V's gate 5, 0161 Oslo

Mailing Address

Postboks 1398, 0114 Oslo